EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endocytosis of insulin at the blood-brain barrier

Sarah Pemberton, Demi C Galindo, Michael W Schwartz, William A Banks, Elizabeth M Rhea

Frontiers in Drug Delivery · 2022

DOI: 10.3389/fddev.2022.1062366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Drug Delivery, 2022. Verfasst von Sarah Pemberton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For insulin to act within the brain, it is primarily transported from the blood across the blood-brain barrier (BBB). However, the endocytic machinery necessary for delivering insulin to the brain remains unknown. Additionally, there are processes within the brain endothelial cell that are designed to respond to insulin binding and elicit intracellular signaling. Using pharmacological inhibitors of different types of endocytosis (clathrin-vs. caveolin-mediated), we investigated molecular mediators of both insulin BBB binding in isolated mouse brain microvessels and BBB insulin transport in mice studied by brain perfusion. We found clathrin-mediated mechanisms responsible for insulin surface binding in isolated brain microvessels while caveolin-mediated endocytosis may mediate BBB insulin transport specifically in the hypothalamus. These results further define the molecular machinery necessary for transporting insulin into the CNS and highlight the distinction between insulin internalization for transendothelial transport vs. intracellular signaling.

Schlagwörter

Stichwörter der Autor:innen

blood-brain barrierendocytosisinsulin receptorinsulin transportmicrovessels

Autor:innen und Institutionen

  • Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States.
  • Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, United States.
  • Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, United States.

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Pemberton, S., Galindo, D. C., Schwartz, M. W., Banks, W. A., & Rhea, E. M. (2022). Endocytosis of insulin at the blood-brain barrier. Frontiers in Drug Delivery. https://doi.org/10.3389/fddev.2022.1062366

Vancouver

Pemberton S, Galindo DC, Schwartz MW, Banks WA, Rhea EM. Endocytosis of insulin at the blood-brain barrier. Frontiers in Drug Delivery. 2022. doi:10.3389/fddev.2022.1062366

BibTeX
@article{Pemberton2022,
  author = {Pemberton, Sarah and Galindo, Demi C and Schwartz, Michael W and Banks, William A and Rhea, Elizabeth M},
  title = {Endocytosis of insulin at the blood-brain barrier},
  journal = {Frontiers in Drug Delivery},
  year = {2022},
  doi = {10.3389/fddev.2022.1062366}
}
Kostenlos starten →